FdaApplication
NDA 020412
Identifiers
- fda_app_no: NDA020412
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 1994-06-24 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZERIT | STAVUDINE | 5MG | CAPSULE;ORAL |
| ZERIT | STAVUDINE | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| ZERIT | STAVUDINE | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| ZERIT | STAVUDINE | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| ZERIT | STAVUDINE | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
5 products